Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CLTA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ARID4B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PSMD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATG101 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHMP2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SERINC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNHIT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
U2AF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LMNA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL13AP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TPR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101930416 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCTD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IQCJ-SCHIP1-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM83H - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SDHA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRMT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNRC6A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRT19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMED1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on